These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7544059

  • 1. [Obsessive-compulsive disorder and depression].
    López-Ibor Aliño JJ, Saiz Ruiz J, López-Ibor Alcocer MI, Viñas Pifarre R.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(3):97-113. PubMed ID: 7544059
    [Abstract] [Full Text] [Related]

  • 2. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS.
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [Abstract] [Full Text] [Related]

  • 3. Depressive and anxiety disorder comorbidity in obsessive compulsive disorder.
    Bhattacharyya S, Reddy YC, Khanna S.
    Psychopathology; 2005 Dec; 38(6):315-9. PubMed ID: 16224205
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
    Meltzer H, Bastani B, Jayathilake K, Maes M.
    Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 6. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A network perspective on comorbid depression in adolescents with obsessive-compulsive disorder.
    Jones PJ, Mair P, Riemann BC, Mugno BL, McNally RJ.
    J Anxiety Disord; 2018 Jan; 53():1-8. PubMed ID: 29125957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of depressive and anxiety disorder comorbidity on the clinical expression of obsessive-compulsive disorder.
    Viswanath B, Narayanaswamy JC, Rajkumar RP, Cherian AV, Kandavel T, Math SB, Reddy YC.
    Compr Psychiatry; 2012 Aug; 53(6):775-82. PubMed ID: 22136738
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
    McCracken JT, Hanna GL.
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.